Evidence map›Paper›PMID 32024010›Full record

ReviewBrain sciences2020

Using Light for Therapy of Glioblastoma Multiforme (GBM).

Alex Vasilev, Roba Sofi, Ruman Rahman, Stuart J Smith, Anja G Teschemacher, Sergey Kasparov

Open access · goldAbstract readReview
In one paragraph

Review in Brain sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. PTPRN promotes glioma cell proliferation, migration, and invasion by regulating the EMT pathway.International journal of clinical and experimental pathology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Alex VasilevSchool of Physiology Pharmacology and Neuroscience, University of Bristol, Bristol BS8 1TD, UK.
Roba SofiSchool of Physiology Pharmacology and Neuroscience, University of Bristol, Bristol BS8 1TD, UK.
Ruman RahmanChildren's Brain Tumour Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Stuart J SmithChildren's Brain Tumour Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Anja G TeschemacherSchool of Physiology Pharmacology and Neuroscience, University of Bristol, Bristol BS8 1TD, UK.
Sergey KasparovSchool of Physiology Pharmacology and Neuroscience, University of Bristol, Bristol BS8 1TD, UK.
Immanuel Kant Baltic Federal University · RUUniversity of Bristol · GBUniversity of Nottingham · GB

Funding

Baltic federal university 5/100 programmeKing Abdulaziz University 5595
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

glioblastoma multiformephotodynamic therapyphotosensitiser

Identifiers

PMID32024010
PMCPMC7071600
OpenAlexW3004400064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.